French beauty conglomerate L'Oréal stands poised to finalize one of 2025's most significant beauty acquisitions with its €1 billion purchase of UK clinical skincare pioneer Medik8 . This...
In a landmark move with national implications, Oregon lawmakers passed Senate Bill 951 on May 28, 2025, enacting the most comprehensive state-level restrictions on corporate control of medical...
Sanofi's landmark $9.1 billion acquisition of Blueprint Medicines marks a pivotal shift in the global biopharma landscape, combining immediate revenue generation with long-term immunology pipeline...
As healthcare systems grapple with post-pandemic financial pressures and evolving care delivery models, Ascension Health's potential $3.9 billion acquisition of AmSurg represents a watershed moment...
The telehealth sector witnessed a transformative move on June 3, 2025, as Hims & Hers Health (NYSE: HIMS) announced its acquisition of ZAVA, a leading European digital health platform. This $1.2...
As Merck & Co. confronts the impending 2028 patent expiration of its $29.5 billion oncology blockbuster Keytruda, the pharmaceutical giant's reported $3 billion pursuit of MoonLake...
In a landmark move signaling deeper convergence between optical manufacturing and clinical care, EssilorLuxottica announced its acquisition of Optegra Eye Health Care from private equity firm...
McKesson Corporation solidified its position in community oncology with the June 2025 completion of its $2.49 billion acquisition of 70% controlling interest in Core Ventures, the administrative arm...
Bruker Corporation's $BRKR acquisition of Austrian metabolomics leader Biocrates Life Sciences AG marks a pivotal expansion in the $12.7 billion multiomics sector . This undisclosed-value...
Checkpoint Therapeutics' proposed acquisition by Sun Pharmaceutical Industries has encountered significant legal challenges as shareholders file suit in Delaware's Court of Chancery. The litigation...
